David S Goldfarb

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Venues

Urolithiasis

Clinical journal of the American Society of Nephrology : CJASN

Healthcare (Basel, Switzerland)

The New England journal of medicine

NYU School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU School of Medicine Jul 01 1982

United States

Professor (Clinical) of Medicine and Neuroscience and Physiology (Academic) :: Medicine. Nephrology

New York Harbor VA Healthcare System Jul 01 1981

United States

Chief, Nephrology Section :: Nephrology Section

Publications

David S Goldfarb, John C Lieske, Jaap Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak
Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4). Urolithiasis 51 (1) (2023)
Carmen Lefaucheur, David S Goldfarb
Thiazide Use for the Prevention of Recurrent Calcium Kidney Stones. Clinical journal of the American Society of Nephrology : CJASN (2023)
Kyriaki Stamatelou, David S Goldfarb
Epidemiology of Kidney Stones. Healthcare (Basel, Switzerland) 11 (3) (2023)
Kyriaki Stamatelou, David S Goldfarb
Epidemiology of Kidney Stones. Healthcare (Basel, Switzerland) 11 (3) (2023)
Carmen Lefaucheur, David S Goldfarb
Thiazide Use for the Prevention of Recurrent Calcium Kidney Stones. Clinical journal of the American Society of Nephrology : CJASN (2023)
Sarah M Azer, David S Goldfarb
A Summary of Current Guidelines and Future Directions for Medical Management and Monitoring of Patients with Cystinuria. Healthcare (Basel, Switzerland) 11 (5) (2023)
Sarah M Azer, David S Goldfarb
A Summary of Current Guidelines and Future Directions for Medical Management and Monitoring of Patients with Cystinuria. Healthcare (Basel, Switzerland) 11 (5) (2023)
David S Goldfarb, Frank Modersitzki, John R Asplin, Lama Nazzal
Correction to: Effect of a high-citrate beverage on urine chemistry in patients with calcium kidney stones. Urolithiasis 51 (1) (2023)
David S Goldfarb, John C Lieske, Jaap Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak
Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4). Urolithiasis 51 (1) (2023)
David S Goldfarb, John C Lieske, Jaap Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak
Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4). Urolithiasis 51 (1) (2023)
David S Goldfarb, Frank Modersitzki, John R Asplin, Lama Nazzal
Effect of a high-citrate beverage on urine chemistry in patients with calcium kidney stones. Urolithiasis 51 (1) (2023)
David S Goldfarb, John C Lieske, Jaap Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak
Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4). Urolithiasis 51 (1) (2023)
David S Goldfarb, John C Lieske, Jaap Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak
Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4). Urolithiasis 51 (1) (2023)
Carmen Lefaucheur, David S Goldfarb
Thiazide Use for the Prevention of Recurrent Calcium Kidney Stones. Clinical journal of the American Society of Nephrology : CJASN (2023)
Carmen Lefaucheur, David S Goldfarb
Thiazide Use for the Prevention of Recurrent Calcium Kidney Stones. Clinical journal of the American Society of Nephrology : CJASN (2023)
David S Goldfarb
Preemptive Removal of Small, Asymptomatic Kidney Stones. The New England journal of medicine 387 (6) (2022)
Sitalakshmi J Iyer, David S Goldfarb
Effects of ambient temperature and humidity on kidney stone admissions in Brazil. Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 42 (2) (2021)
David S Goldfarb, Judith A Benstein, Olga Zhdanova, Elizabeth Hammer, Clay A Block, Nina J Caplin, Nathan Thompson, David M Charytan
Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients. Clinical journal of the American Society of Nephrology : CJASN 15 (6) (2020)
Susan Willis, David S Goldfarb, Kay Thomas, Matthew Bultitude
Water to prevent kidney stones: tap vs bottled; soft vs hard - does it matter? BJU international 124 (6) (2019)
Line Malha, Hasan Fattah, Frank Modersitzki, David S Goldfarb
Blood volume analysis as a guide for dry weight determination in chronic hemodialysis patients: a crossover study. BMC nephrology 20 (1) (2019)
Lada Beara-Lasic, David S Goldfarb
Recurrent Calcium Kidney Stones. Clinical journal of the American Society of Nephrology : CJASN 14 (9) (2019)
David S Goldfarb
Empiric therapy for kidney stones. Urolithiasis 47 (1) (2018)

David S Goldfarb.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David S Goldfarb